【3386】コスモ・バイオ

研究用試薬などの商社。

類似企業：

【業界1位】メディパルホールディングス

【売上同水準】レオクラン 星医療酸器

東証スタンダード

卸売業卸売

＞

医薬品・医療機器卸医卸

売上高

営業利益

経常利益

当期利益

業績予想修正

対前回修正率

当初予想比較

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.12	2025/02/14	当初予	10,700	-	-	-	490	-	-	-	580	-	-	-	430	-	-	-
2024.12	2025/02/14	実	10,037	↑	+2.4%	+2.4%	318	↓	-18.5%	-18.5%	364	↓	-19.1%	-19.1%	262	↓	-15.5%	-15.5%
2024.12	2024/11/07	Q3予	9,800	→	0.0%	0.0%	390	→	0.0%	0.0%	450	→	0.0%	0.0%	310	→	0.0%	0.0%
2024.12	2024/08/05	Q2予	9,800	→	0.0%	0.0%	390	→	0.0%	0.0%	450	→	0.0%	0.0%	310	→	0.0%	0.0%
2024.12	2024/05/09	Q1予	9,800	→	0.0%	0.0%	390	→	0.0%	0.0%	450	→	0.0%	0.0%	310	→	0.0%	0.0%
2024.12	2024/02/14	当初予	9,800	-	-	-	390	-	-	-	450	-	-	-	310	-	-	-
2023.12	2024/02/14	実	9,340	↓	-4.7%	-4.7%	519	↓	-13.5%	-13.5%	653	↓	-1.1%	-1.1%	442	↓	-1.8%	-1.8%
2023.12	2023/11/07	Q3予	9,800	→	0.0%	0.0%	600	→	0.0%	0.0%	660	→	0.0%	0.0%	450	→	0.0%	0.0%
2023.12	2023/08/04	Q2予	9,800	→	0.0%	0.0%	600	→	0.0%	0.0%	660	→	0.0%	0.0%	450	→	0.0%	0.0%
2023.12	2023/05/10	Q1予	9,800	→	0.0%	0.0%	600	→	0.0%	0.0%	660	→	0.0%	0.0%	450	→	0.0%	0.0%
2023.12	2023/02/14	当初予	9,800	-	-	-	600	-	-	-	660	-	-	-	450	-	-	-
2022.12	2023/02/14	実	9,553	↓	-0.5%	+1.6%	816	↑	+16.6%	-1.7%	790	↑	+11.3%	-9.2%	517	↑	+10.0%	-10.9%
2022.12	2022/11/07	Q3予	9,600	→	0.0%	+2.1%	700	→	0.0%	-15.7%	710	→	0.0%	-18.4%	470	→	0.0%	-19.0%
2022.12	2022/08/04	Q2予	9,600	→	0.0%	+2.1%	700	→	0.0%	-15.7%	710	→	0.0%	-18.4%	470	→	0.0%	-19.0%
2022.12	2022/07/25	修正予	9,600	↑	+2.1%	+2.1%	700	↓	-15.7%	-15.7%	710	↓	-18.4%	-18.4%	470	↓	-19.0%	-19.0%
2022.12	2022/05/10	Q1予	9,400	→	0.0%	0.0%	830	→	0.0%	0.0%	870	→	0.0%	0.0%	580	→	0.0%	0.0%
2022.12	2022/02/14	当初予	9,400	-	-	-	830	-	-	-	870	-	-	-	580	-	-	-
2021.12	2022/02/14	実	9,231	↑	+2.6%	+12.6%	1,048	↑	+16.4%	+49.7%	1,099	↑	+15.7%	+46.5%	737	↑	+17.0%	+53.5%
2021.12	2021/11/05	Q3予	9,000	→	0.0%	+9.8%	900	→	0.0%	+28.6%	950	→	0.0%	+26.7%	630	→	0.0%	+31.3%
2021.12	2021/08/05	Q2予	9,000	→	0.0%	+9.8%	900	↑	+28.6%	+28.6%	950	→	0.0%	+26.7%	630	→	0.0%	+31.3%
2021.12	2021/07/27	修正予	9,000	↑	+9.8%	+9.8%	-	-	-	-	950	↑	+26.7%	+26.7%	630	↑	+31.3%	+31.3%
2021.12	2021/05/10	Q1予	8,200	→	0.0%	0.0%	700	→	0.0%	0.0%	750	→	0.0%	0.0%	480	→	0.0%	0.0%
2021.12	2021/02/12	当初予	8,200	-	-	-	700	-	-	-	750	-	-	-	480	-	-	-
2020.12	2021/02/12	実	8,092	↑	+3.7%	+4.4%	752	↑	+27.5%	+74.9%	817	↑	+23.8%	+66.7%	674	↑	+24.8%	+117.4%
2020.12	2020/11/06	Q3予	7,800	→	0.0%	+0.6%	590	→	0.0%	+37.2%	660	→	0.0%	+34.7%	540	→	0.0%	+74.2%
2020.12	2020/08/05	Q2予	7,800	→	0.0%	+0.6%	590	→	0.0%	+37.2%	660	→	0.0%	+34.7%	540	→	0.0%	+74.2%
2020.12	2020/07/21	修正予	7,800	↑	+0.6%	+0.6%	590	↑	+37.2%	+37.2%	660	↑	+34.7%	+34.7%	540	↑	+74.2%	+74.2%
2020.12	2020/05/11	Q1予	7,750	→	0.0%	0.0%	430	→	0.0%	0.0%	490	→	0.0%	0.0%	310	→	0.0%	0.0%
2020.12	2020/02/14	当初予	7,750	-	-	-	430	-	-	-	490	-	-	-	310	-	-	-
2019.12	2020/02/14	実	7,590	↑	+2.6%	+2.6%	405	↑	+15.7%	+102.5%	470	↑	+22.1%	+88.0%	237	↓	-5.2%	+69.3%
2019.12	2019/11/06	Q3予	7,400	→	0.0%	0.0%	350	→	0.0%	+75.0%	385	→	0.0%	+54.0%	250	→	0.0%	+78.6%
2019.12	2019/08/05	Q2予	7,400	→	0.0%	0.0%	350	→	0.0%	+75.0%	385	→	0.0%	+54.0%	250	→	0.0%	+78.6%
2019.12	2019/07/23	修正予	7,400	→	0.0%	0.0%	350	↑	+75.0%	+75.0%	385	↑	+54.0%	+54.0%	250	↑	+78.6%	+78.6%
2019.12	2019/05/10	Q1予	7,400	→	0.0%	0.0%	200	→	0.0%	0.0%	250	→	0.0%	0.0%	140	→	0.0%	0.0%
2019.12	2019/02/14	当初予	7,400	-	-	-	200	-	-	-	250	-	-	-	140	-	-	-
2018.12	2019/02/14	実	7,261	→	0.0%	-3.2%	328	↑	+0.6%	+68.2%	403	↑	+0.2%	+64.5%	260	↑	+0.4%	+73.3%
2018.12	2019/01/31	修正予	7,261	↓	-3.2%	-3.2%	326	↑	+67.2%	+67.2%	402	↑	+64.1%	+64.1%	259	↑	+72.7%	+72.7%
2018.12	2018/11/05	Q3予	7,500	→	0.0%	0.0%	195	→	0.0%	0.0%	245	→	0.0%	0.0%	150	→	0.0%	0.0%
2018.12	2018/08/03	Q2予	7,500	→	0.0%	0.0%	195	-	-	-	245	→	0.0%	0.0%	150	→	0.0%	0.0%
2018.12	2018/05/08	Q1予	7,500	-	-	-	-	-	-	-	245	-	-	-	150	-	-	-
2017.12	2018/02/14	修正予	7,068	↓	-1.8%	-5.8%	193	↑	+37.9%	+67.8%	397	↑	+10.3%	+120.6%	237	↑	+3.0%	+125.7%
2017.12	2017/11/06	Q3予	7,200	→	0.0%	-4.0%	140	→	0.0%	+21.7%	360	→	0.0%	+100.0%	230	→	0.0%	+119.0%
2017.12	2017/08/04	修正予	7,200	↓	-4.0%	-4.0%	140	↑	+21.7%	+21.7%	360	↑	+100.0%	+100.0%	230	↑	+119.0%	+119.0%
2017.12	2017/05/09	Q1予	7,500	→	0.0%	0.0%	115	→	0.0%	0.0%	180	→	0.0%	0.0%	105	→	0.0%	0.0%
2017.12	2017/02/14	当初予	7,500	-	-	-	115	-	-	-	180	-	-	-	105	-	-	-
2016.12	2017/02/14	実	7,427	↓	-2.3%	-4.2%	514	↑	+28.5%	+328.3%	483	↑	+27.1%	+119.5%	254	↑	+5.8%	+111.7%
2016.12	2016/11/07	Q3予	7,600	→	0.0%	-1.9%	400	→	0.0%	+233.3%	380	→	0.0%	+72.7%	240	→	0.0%	+100.0%
2016.12	2016/08/05	修正予	7,600	↓	-1.9%	-1.9%	400	↑	+233.3%	+233.3%	380	↑	+72.7%	+72.7%	240	↑	+100.0%	+100.0%
2016.12	2016/02/12	当初予	7,750	-	-	-	120	-	-	-	220	-	-	-	120	-	-	-
2015.12	2016/02/12	実	7,357	→	0.0%	-5.2%	200	→	0.0%	+185.7%	373	→	0.0%	+86.5%	230	↓	-0.4%	+91.7%
2015.12	2016/01/27	修正予	7,357	↓	-5.2%	-5.2%	200	↑	+122.2%	+185.7%	373	↑	+38.1%	+86.5%	231	↑	+44.4%	+92.5%
2015.12	2015/11/09	Q3予	7,760	→	0.0%	0.0%	90	→	0.0%	+28.6%	270	→	0.0%	+35.0%	160	→	0.0%	+33.3%
2015.12	2015/08/10	修正予	7,760	→	0.0%	0.0%	90	↑	+28.6%	+28.6%	270	↑	+35.0%	+35.0%	160	↑	+33.3%	+33.3%
2015.12	2015/05/08	Q1予	7,760	→	0.0%	0.0%	70	-	-	-	200	→	0.0%	0.0%	120	→	0.0%	0.0%
2015.12	2015/02/13	当初予	7,760	-	-	-	-	-	-	-	200	-	-	-	120	-	-	-
2014.12	2015/02/13	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2014.12	2015/01/26	修正予	7,235	↓	-0.9%	-0.9%	-	-	-	-	285	↓	-30.5%	-27.7%	201	↓	-24.2%	-13.7%
2014.12	2014/11/06	Q3予	7,300	→	0.0%	0.0%	260	→	0.0%	+0.8%	410	→	0.0%	+4.1%	265	→	0.0%	+13.7%
2014.12	2014/08/07	修正予	7,300	→	0.0%	0.0%	260	↑	+0.8%	+0.8%	410	↑	+4.1%	+4.1%	265	↑	+13.7%	+13.7%
2014.12	2014/05/08	Q1予	7,300	→	0.0%	0.0%	258	→	0.0%	0.0%	394	→	0.0%	0.0%	233	→	0.0%	0.0%
2014.12	2014/02/14	当初予	7,300	-	-	-	258	-	-	-	394	-	-	-	233	-	-	-
2013.12	2014/02/14	実	7,050	-	-	-	271	-	-	-	444	-	-	-	313	-	-	-

【3386】コスモ・バイオ 研究用試薬などの商社。 類似企業： 【業界1位】 メディパルホールディングス 【売上同水準】 レオクラン 星医療酸器

【3386】コスモ・バイオ

研究用試薬などの商社。

類似企業：

【業界1位】メディパルホールディングス

【売上同水準】レオクラン星医療酸器